Literature DB >> 16892316

Using ColE1-derived RNA I for suppression of a bacterially encoded gene: implication for a novel plasmid addiction system.

Irene Pfaffenzeller1, Jürgen Mairhofer, Gerald Striedner, Karl Bayer, Reingard Grabherr.   

Abstract

The use of plasmid DNA for gene therapeutical purposes is a novel technology with advantages and drawbacks. One of the required improvements is to avoid antibiotic resistance genes or other additional sequences for selection within the plasmid. Here, we describe an alternative approach to equip a ColE1 plasmid with a regulatory function within the cell, which could be used for selection of plasmid carrying cells. No additional sequences are required, since the mechanism is based on RNA/RNA antisense interaction involving the naturally occurring RNA I derived from the plasmid's origin of replication. The plasmid replicational regulatory network was linked to the transcriptional regulatory network of an engineered target gene, present on the bacterial chromosome. Thus, gene suppression of a reporter could be achieved by mere presence of the ColE1-type plasmid pBR322. Proof of this concept was shown in shaker-flask experiments and fed-batch fermentation processes. The strategy of regulating gene expression by plasmid replication implicates a novel strategy for plasmid selection, as the gene to be suppressed could be toxic or growth hampering, providing advantage to plasmid carrying host cells.

Mesh:

Substances:

Year:  2006        PMID: 16892316     DOI: 10.1002/biot.200600017

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  10 in total

Review 1.  Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA.

Authors:  Juergen Mairhofer; Reingard Grabherr
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

Review 2.  Antibiotic-free selection in biotherapeutics: now and forever.

Authors:  Charlotte Mignon; Régis Sodoyer; Bettina Werle
Journal:  Pathogens       Date:  2015-04-03

3.  Critical design criteria for minimal antibiotic-free plasmid vectors necessary to combine robust RNA Pol II and Pol III-mediated eukaryotic expression with high bacterial production yields.

Authors:  Aaron E Carnes; Jeremy M Luke; Justin M Vincent; Sheryl Anderson; Angela Schukar; Clague P Hodgson; James A Williams
Journal:  J Gene Med       Date:  2010-10       Impact factor: 4.565

4.  Use of mchI encoding immunity to the antimicrobial peptide microcin H47 as a plasmid selection marker in attenuated bacterial live vectors.

Authors:  Chee-Mun Fang; Jin Yuan Wang; Magaly Chinchilla; Myron M Levine; William C Blackwelder; James E Galen
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

5.  Antibiotic-free selection in E. coli: new considerations for optimal design and improved production.

Authors:  Isabelle Peubez; Nicolas Chaudet; Charlotte Mignon; Géraldine Hild; Stéphanie Husson; Virginie Courtois; Karelle De Luca; Denis Speck; Régis Sodoyer
Journal:  Microb Cell Fact       Date:  2010-09-07       Impact factor: 5.328

Review 6.  Plasmid addiction systems: perspectives and applications in biotechnology.

Authors:  Jens Kroll; Stefan Klinter; Cornelia Schneider; Isabella Voss; Alexander Steinbüchel
Journal:  Microb Biotechnol       Date:  2010-11       Impact factor: 5.813

7.  Advances in Non-Viral DNA Vectors for Gene Therapy.

Authors:  Cinnamon L Hardee; Lirio Milenka Arévalo-Soliz; Benjamin D Hornstein; Lynn Zechiedrich
Journal:  Genes (Basel)       Date:  2017-02-10       Impact factor: 4.096

8.  The Antibiotic-free pFAR4 Vector Paired with the Sleeping Beauty Transposon System Mediates Efficient Transgene Delivery in Human Cells.

Authors:  Marie Pastor; Sandra Johnen; Nina Harmening; Mickäel Quiviger; Julie Pailloux; Martina Kropp; Peter Walter; Zoltán Ivics; Zsuzsanna Izsvák; Gabriele Thumann; Daniel Scherman; Corinne Marie
Journal:  Mol Ther Nucleic Acids       Date:  2017-12-30       Impact factor: 8.886

9.  Reduced Heterochromatin Formation on the pFAR4 Miniplasmid Allows Sustained Transgene Expression in the Mouse Liver.

Authors:  Marie Pastor; Mickäel Quiviger; Julie Pailloux; Daniel Scherman; Corinne Marie
Journal:  Mol Ther Nucleic Acids       Date:  2020-05-20       Impact factor: 8.886

Review 10.  Safety Aspects of Genetically Modified Lactic Acid Bacteria.

Authors:  Tina Vida Plavec; Aleš Berlec
Journal:  Microorganisms       Date:  2020-02-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.